Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta-analysis of clinical trials

Multiple myeloma (MM) remains incurable primarily due to relapse. Histone deacetylase inhibitors (HDACis) have shown potential application for the treatment of relapsed/refractory multiple myeloma (RRMM). To assess the efficacy and safety of HDACis in RRMM treatment, a systematic review and meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiao, Shen, Lijing, Li, Xiang, Liu, Jiaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614737/
https://www.ncbi.nlm.nih.gov/pubmed/31363365
http://dx.doi.org/10.3892/etm.2019.7704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614737/
https://www.ncbi.nlm.nih.gov/pubmed/31363365
http://dx.doi.org/10.3892/etm.2019.7704

Ejemplares similares